Federal Health Grants

This funding supports institutions in developing training programs for predoctoral and postdoctoral researchers in biomedical and clinical fields, with a focus on enhancing diversity and preparing trainees for successful research careers.

This FOA invites applications that propose to develop novel research infrastructure that will advance the science of aging in specific areas requiring interdisciplinary partnerships or collaborations.

This funding opportunity supports researchers in developing innovative strategies to eliminate HIV proteins by targeting viral RNA or proteins for degradation, with a focus on advancing new therapeutic approaches.

CDC announces the availability of supplemental funding for the 26 American Indian and Alaska Native (AI/AN) Tribes and regional AI/AN tribally designated organizations awarded funding under CDC-RFA-TO-23-0001: Strengthening Public Health Systems and Services in Indian Country. The CDC-RFA-TO-23-0001 recipients are eligible to submit applications for new FY 2024 Centers, Institute, and Offices (CIO) Project Plans according to the entity type, HHS Region, and/or IHS Area for which they received initial funding.

This funding opportunity supports research projects aimed at developing and planning clinical trials that integrate effective HIV prevention strategies for populations affected by alcohol use, focusing on reducing new HIV infections.

This funding opportunity announcement (FOA) encourages applications that propose to develop studies that will lead to a broad understanding of the natural history of disorders that already do or could potentially benefit from early identification by newborn screening. A comprehensive understanding of the natural history of a disorder has been identified as a necessary element to facilitate appropriate interventions for infants identified by newborn screening. By defining the sequence and timing of the onset of symptoms and complications of a disorder, a valuable resource will be developed for the field. In addition, for some disorders, specific genotype-phenotype correlations may allow prediction of the clinical course, and for other disorders, identification of modifying genetic, epigenetic, or environmental factors will enhance an understanding of the clinical outcomes for an individual with such a condition. Comprehensive data on natural history will facilitate the field;apos;s ability to: 1) accurately diagnose the disorder; 2) understand the genetic and clinical heterogeneity and phenotypic expression of the disorder; 3) identify underlying mechanisms related to basic defects; 4) potentially prevent, manage, and treat symptoms and complications of the disorder; and 5) provide children and their families with needed support and predictive information about the disorder.

This grant provides funding for researchers to conduct multi-site clinical trials focused on effective treatments and preventive interventions for health issues related to aging, specifically targeting older adults with complex health conditions.

This grant provides funding to nonprofit organizations, local governments, and tribal communities in the U.S. to support innovative arts projects that engage the public and strengthen community connections.

This funding opportunity provides financial support for organizations to develop and implement innovative strategies for tuberculosis prevention and detection in high-burden countries, focusing on treatment optimization and improved case finding.

This funding opportunity provides financial support to early-career researchers from diverse backgrounds to develop innovative cancer research projects and enhance workforce diversity in the field.

The National Institute on Aging (NIA), part of the National Institutes of Health (NIH), intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications that propose to establish a national Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-related Dementias (ADRD) Primary Prevention Trials. The Network will serve as a centralized hub for developing, validating, standardizing, and disseminating measures and measurement methods for AD/ADRD primary prevention trials. It will incorporate measures and measurement methods across neuropsychological, biomarker, and functional domains to meet the goal of primary prevention of AD/ADRD centered around brain health equity. Brain health equity is the fair distribution of brain health determinants, outcomes, and resources within and between segments of the population, regardless of social standing. Measures and methods of interest will test outcomes and mechanisms of action in settings customized for individuals with different needs and linked to real-world function. Applications must explain how the platform will meet evolving community needs and partner with other NIA-funded programs. Applications must also describe activities that will achieve the following objectives: Develop an organizational and governance structure to support the administration, innovation, and dissemination functions of the Network. Propose activities to establish a framework that will facilitate the development of innovative strategies for standardization and use of methods and measures across NIA-supported projects and support activities for the discovery and development of innovative and novel measures and data. Disseminate Network resources and products to the broader AD/ADRD research community. Ensure that all measures and methods development and validation occurs in a racially, ethnically, geographically, and diagnostically diverse set of participants, including members of NIH-defined Health Disparity Populations. This also includes establishing the acceptability and feasibility of using the proposed instruments in both cognitively normal individuals and persons living with cognitive impairment (PLWCI), including subjective cognitive decline. NIA is particularly interested in proposals that advance equity for populations disproportionately impacted by AD/ADRD. For example, Black and Hispanic Americans have a higher prevalence of AD/ADRD compared to non-Hispanic White Americans. Resources, including measurement instruments, methods, algorithms, code, documentation, and normative data will enable other, future measures and methods development projects that support AD/ADRD primary prevention research needs. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in early 2024 with an expected application due date in Spring/Summer 2024. This NOFO will utilize the U24 activity code.

The NICHD Small Research Grant Program (R03 Clinical Trial Required) supports clinical trials that fall within the NICHD mission. The R03 activity code supports small research projects that can be carried out in a short period of time with limited resources. The R03 program may be used for different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.

Dear Potential Applicant/Offeror, USAID/Mozambique intends to design a new HIV Activity - SUstaining Control the HIV Epidemic through quality Services, resilient Systems, and Community Outreach (SUCESSO) - that will support and contribute to the Government of the Republic of Mozambique (GRM) to reach and sustain HIV epidemic control in four provinces - Sofala, Manica, Tete and Niassa. This is anticipated to be a five (5) year award(s) - 2026 - 2031, with a total value of up to $155 million. The purpose of this communication is to obtain industry comment and input on the above-mentioned program. More specifically, the RFI intends to: Assess the interest of potential organizations in submitting applications/proposals for the new Activity - SUCESSO. Gain technical and organizational insights in the capacity of potential organizations. Explore innovative approaches to partnering with organizations working in the same area; and Collect inputs to contribute to the improvement of the proposed Program Description (PD)/Statement of Work (SOW).

This funding opportunity supports research projects aimed at improving cancer care and outcomes for sexual and gender minority survivors by addressing healthcare disparities and enhancing access to quality treatment.

This funding opportunity provides financial support for organizations to evaluate and implement overdose prevention strategies targeting communities disproportionately affected by substance use disorders and overdose deaths.

This funding opportunity supports interdisciplinary research teams to explore how medical devices can effectively relieve chronic pain while minimizing addiction risks.

This funding opportunity provides additional financial support to active health services research projects facing unforeseen costs, helping researchers continue their work effectively.

This funding opportunity is designed to support multidisciplinary teams in developing innovative therapies and medical devices for treating visual system diseases, advancing promising preclinical research towards clinical application.

This funding opportunity supports independent research projects that aim to improve health outcomes and promote health equity through innovative and inclusive approaches, particularly in nursing and related fields.

The DWS Grant Program has been established to help individuals with low to moderate incomes finance the costs of household water wells and individually owned decentralized wastewater systems that they own or will own. Grant funds must be used to establish and maintain a revolving fund to provide loans and sub-grants to eligible individuals for individually owned water well systems and/or individually owned wastewater systems. Individual households may use the loan and/or sub-grant funds to construct, refurbish, rehabilitate, or replace decentralized water systems up to the point of entry to a home. Point of entry for the well system is the junction where water enters into a home water delivery system after being pumped from a well. For septic systems, in lieu of the point of entry, the point of exit is substituted. The point of exit is the junction where wastewater exits out of the home wastewater collection system into the septic tank and drain field. Grant funds may be used to pay administrative expenses associated with providing DWS loans and/or sub-grants.